文献速递慢性肾脏病遗传性与小管间质肾病

APOL1风险变异通过线粒体转位及开放通透性转换孔诱导细胞死亡

APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.
PubMed 文献 · J Am Soc Nephrol · 2019-09-26

该研究在HEK293 T-REx细胞中稳定表达APOL1非风险G0或风险变异,发现两者均进入线粒体基质,但只有风险变异形成高阶寡聚体并激活线粒体通透性转换孔开放,导致细胞死亡;阻断线粒体输入可消除寡聚化并挽救毒性。

要点

  • APOL1风险变异与G0共享线粒体输入途径,但风险变异倾向形成高阶寡聚体。
  • 风险变异结合线粒体通透性转换孔组分并激活孔开放,G0不激活。
  • 阻断线粒体输入可减少寡聚体形成并挽救风险变异诱导的毒性。

核心结论

  • APOL1风险变异通过形成高阶寡聚体并激活线粒体通透性转换孔开放诱导细胞死亡,寡聚化模式差异可能解释其隐性功能获得性生物学。

研究设计与样本

  • 研究使用四环素诱导的HEK293 T-REx细胞系稳定表达APOL1非风险G0或风险变异,通过siRNA敲低、药理学抑制剂、蓝原生PAGE、质谱和线粒体通透性转换孔功能评估解析分子通路。

主要发现

  • APOL1 G0和风险变异蛋白共享进入线粒体基质的输入途径;进入后G0保持单体,而风险变异蛋白易形成高阶寡聚体。
  • 非风险G0和风险变异蛋白均结合线粒体通透性转换孔组分,但仅风险变异蛋白激活孔开放。
  • 阻断APOL1风险变异的线粒体输入大幅减少寡聚体形成并挽救毒性。

临床怎么用

  • 该机制提示APOL1风险变异的寡聚化及线粒体通透性转换孔开放可能作为潜在干预靶点,但尚需进一步临床验证。

局限性

  • 研究基于HEK293 T-REx细胞模型,未在人类肾脏组织或临床队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic Variants in Apolipoprotein L1 (APOL1) are associated with large increases in CKD rates among African Americans. Experiments in cell and mouse models suggest that these risk-related polymorphisms are toxic gain-of-function variants that cause kidney dysfunction, following a recessive mode of inheritance. Recent data in trypanosomes and in human cells indicate that such variants may cause toxicity through their effects on mitochondria. METHODS: To examine the molecular mechanisms underlying APOL1 risk variant-induced mitochondrial dysfunction, we generated tetracycline-inducible HEK293 T-REx cells stably expressing the APOL1 nonrisk G0 variant or APOL1 risk variants. Using these cells, we mapped the molecular pathway from mitochondrial import of APOL1 protein to APOL1-induced cell death with small interfering RNA knockdowns, pharmacologic inhibitors, blue native PAGE, mass spectrometry, and assessment of mitochondrial permeability transition pore function. RESULTS: We found that the APOL1 G0 and risk variant proteins shared the same import pathway into the mitochondrial matrix. Once inside, G0 remained monomeric, whereas risk variant proteins were prone to forming higher-order oligomers. Both nonrisk G0 and risk variant proteins bound components of the mitochondrial permeability transition pore, but only risk variant proteins activated pore opening. Blocking mitochondrial import of APOL1 risk variants largely eliminated oligomer formation and also rescued toxicity. CONCLUSIONS: Our study illuminates important differences in the molecular behavior of APOL1 nonrisk and risk variants, and our observations suggest a mechanism that may explain the very different functional effects of these variants, despite the lack of consistently observed differences in trafficking patterns, intracellular localization, or binding partners. Variant-dependent differences in oligomerization pattern may underlie APOL1's recessive, gain-of-function biology.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Shah SS, Lannon H, Dias L, et al. APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore. J Am Soc Nephrol. 2019. PMID: 31558683. doi:10.1681/ASN.2019020114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。